AR060089A1 - Tratamiento del dolor - Google Patents
Tratamiento del dolorInfo
- Publication number
- AR060089A1 AR060089A1 ARP070101211A ARP070101211A AR060089A1 AR 060089 A1 AR060089 A1 AR 060089A1 AR P070101211 A ARP070101211 A AR P070101211A AR P070101211 A ARP070101211 A AR P070101211A AR 060089 A1 AR060089 A1 AR 060089A1
- Authority
- AR
- Argentina
- Prior art keywords
- pain
- pain treatment
- mammal
- compound
- formula
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Esta invencion proporciona un método para tratar el dolor en un mamífero que incluye administrar a un mamífero que necesita dicho tratamiento una cantidad efectiva para tratar el dolor de un compuesto de la Formula (1): o una sal farmacéuticamente aceptable del mismo, donde cada uno de R1, R2, R3, R4, R5, R6, n, y m es como se definio y describio en la presente. La presente invencion también proporciona composiciones farmacéuticas para tratar el dolor que contienen una cantidad efectiva para tratar el dolor de un compuesto de Formula 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78563306P | 2006-03-24 | 2006-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060089A1 true AR060089A1 (es) | 2008-05-21 |
Family
ID=38332439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101211A AR060089A1 (es) | 2006-03-24 | 2007-03-23 | Tratamiento del dolor |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070225277A1 (es) |
EP (1) | EP1998781A2 (es) |
JP (1) | JP2009531434A (es) |
KR (1) | KR20080110759A (es) |
CN (1) | CN101410118A (es) |
AR (1) | AR060089A1 (es) |
AU (1) | AU2007230997A1 (es) |
BR (1) | BRPI0709163A2 (es) |
CA (1) | CA2644656A1 (es) |
EC (1) | ECSP088762A (es) |
IL (1) | IL193748A0 (es) |
MX (1) | MX2008012092A (es) |
PA (1) | PA8720901A1 (es) |
PE (1) | PE20081192A1 (es) |
TW (1) | TW200806299A (es) |
WO (1) | WO2007112000A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
AR060088A1 (es) * | 2006-03-24 | 2008-05-21 | Wyeth Corp | Metodos para tratar trastornos cognitivos y otros afines |
CA2644662A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment of depression |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
CA2946445C (en) | 2008-05-20 | 2019-01-08 | Acorda Therapeutics, Inc. | Hepatoprotectant acetaminophen mutual prodrugs |
WO2010124042A2 (en) | 2009-04-23 | 2010-10-28 | Abbott Laboratories | Modulators of 5-ht receptors and methods of use thereof |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8546377B2 (en) * | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
NZ618902A (en) | 2009-05-22 | 2015-06-26 | Abbvie Inc | Modulators of 5-ht receptors and methods of use thereof |
US20120253036A1 (en) * | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
CN104860951A (zh) * | 2010-05-21 | 2015-08-26 | Abbvie公司 | 5-ht受体的调节剂和其使用方法 |
BR112015005743A2 (pt) | 2012-09-14 | 2017-07-04 | Abbvie Deutschland | derivados tricíclicos de quinoxalina e quinolina |
US20140080813A1 (en) | 2012-09-14 | 2014-03-20 | AbbVie Deutschland GmbH & Co. KG | Tricyclic quinoline and quinoxaline derivatives |
WO2015136090A1 (en) | 2014-03-14 | 2015-09-17 | AbbVie Deutschland GmbH & Co. KG | Hexahydrodiazepinoquinolines carrying a cyclic radical |
US9540376B2 (en) | 2014-03-14 | 2017-01-10 | AbbVie Deutschland GmbH & Co. KG | Hexahydrodiazepinoquinolines carrying a substituted alkyl radical |
WO2016210431A1 (en) * | 2015-06-26 | 2016-12-29 | Wright State University | Method of treating sepsis-induced myopathy |
US20180339996A1 (en) | 2015-11-25 | 2018-11-29 | AbbVie Deutschland GmbH & Co. KG | Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders |
US20200039930A1 (en) | 2017-03-21 | 2020-02-06 | AbbVie Deutschland GmbH & Co. KG | Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radical |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3158619A (en) * | 1962-06-14 | 1964-11-24 | Searle & Co | Certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3235564A (en) * | 1964-03-27 | 1966-02-15 | Searle & Co | Intermediates to certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3296252A (en) * | 1964-04-02 | 1967-01-03 | Sandoz Ag | Tetracyclic diazepinone compounds |
US3335134A (en) * | 1964-04-02 | 1967-08-08 | Sandoz Ag | Certain 3, 4-dihydrofluoreno[1, 9a, 9-e, f]1, 4-diazepin-3(2h)-ones |
GB1120463A (en) * | 1964-07-06 | 1968-07-17 | Manuf Prod Pharma | Derivatives of 1,3-diazafluoranthene-1-oxide |
US3417101A (en) * | 1964-11-09 | 1968-12-17 | American Home Prod | Fused ring compounds |
US3329676A (en) * | 1964-11-09 | 1967-07-04 | American Home Prod | Fused 1, 4-diazepine ring systems |
US3714149A (en) * | 1969-11-03 | 1973-01-30 | Upjohn Co | Pyridobenzodiazepinones |
US3914250A (en) * | 1974-08-01 | 1975-10-21 | American Home Prod | 1,4-Diazepino{8 6,5,4-jk{9 carbazoles |
US4880814A (en) * | 1987-11-13 | 1989-11-14 | Abbott Laboratories | 7-cycloalkyl naphthyridines |
GB8812636D0 (en) * | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
US4997831A (en) * | 1988-09-01 | 1991-03-05 | Glaxo Group Limited | Lactam derivatives |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
ES2284741T3 (es) * | 1994-06-15 | 2007-11-16 | Otsuka Pharmaceutical Company, Limited | Derivados de benzoheterociclicos utilizados como moduladores de vasoprsinao de oxitocina. |
US5565483A (en) * | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
US5654334A (en) * | 1995-06-23 | 1997-08-05 | Oklahoma Medical Research Foundation | Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester |
TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6194407B1 (en) * | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US6031098A (en) * | 1997-08-11 | 2000-02-29 | California Institute Of Technology | Detection and treatment of duplex polynucleotide damage |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
CO5210925A1 (es) * | 1998-11-17 | 2002-10-30 | Novartis Ag | Derivados de diamino nitroguanidina tetrasustituidos |
CA2374898C (en) * | 1999-05-21 | 2009-12-08 | Biovitrum Ab | Pyrazinyl-piperazine compounds, their use and preparation |
US6465467B1 (en) * | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
US6784172B2 (en) * | 2000-11-03 | 2004-08-31 | Wyeth | Processes for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
US6414144B1 (en) * | 2000-11-03 | 2002-07-02 | Wyeth | Process for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi] indole derivatives |
US6759405B2 (en) * | 2000-11-03 | 2004-07-06 | Wyeth | Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
US6503900B2 (en) * | 2000-11-03 | 2003-01-07 | Wyeth | [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives |
AR031202A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados |
AR031195A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta (b) (1,4) diazepino (6,7,1) diazepino (6,7,1-hi) indol |
US6858604B2 (en) * | 2000-11-03 | 2005-02-22 | Wyeth | Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
AR031197A1 (es) * | 2000-11-03 | 2003-09-10 | Wyeth Corp | Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta(b) diazepino(6,7,1-hi)indol |
SE0004245D0 (sv) * | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
US6849619B2 (en) * | 2000-12-20 | 2005-02-01 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
ATE438646T1 (de) * | 2000-12-20 | 2009-08-15 | Bristol Myers Squibb Co | Substituierte pyrrolochinoline und pyridochinoline als serotonin- agonisten und- antagonisten |
US6699852B2 (en) * | 2000-12-20 | 2004-03-02 | Bristol-Myers Squibb Pharma Company | Substituted pyridoindoles as serotonin agonists and antagonists |
BR0207673A (pt) * | 2001-02-27 | 2004-12-28 | Ortho Mcneil Pharm Inc | Compostos de carbamato para o uso no tratamento de dor |
US20020183395A1 (en) * | 2001-04-04 | 2002-12-05 | Wyeth | Methods for treating hyperactive gastric motility |
JP2005501092A (ja) * | 2001-08-06 | 2005-01-13 | ファルマシア・アンド・アップジョン・カンパニー | 治療上有用な四環リガンド |
BR0213417A (pt) * | 2001-10-18 | 2004-11-03 | Upjohn Co | Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos |
TWI312781B (en) * | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307682A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
TW200307540A (en) * | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
SE0201544D0 (sv) * | 2002-05-17 | 2002-05-17 | Biovitrum Ab | Novel compounds and thier use |
US20040235856A1 (en) * | 2003-04-25 | 2004-11-25 | Pfizer Inc | Treatment of incontinence |
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR052227A1 (es) * | 2004-11-05 | 2007-03-07 | Wyeth Corp | Metabolitos derivados de [1,4] diazepin [ 6,7,1-ij] quinolina, metodos de preparacion y usos de los mismos |
AR051946A1 (es) * | 2004-11-05 | 2007-02-21 | Wyeth Corp | Formulaciones de derivados de [1,4] diazepina [6,7,1-ij] quinolina |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
AR056695A1 (es) * | 2005-10-17 | 2007-10-17 | Wyeth Corp | Tetrahidroquinolinas, su sintesis e intermediarios |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
CA2644639A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment or prevention of psychotic disorders |
CA2644662A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment of depression |
EP1998782A2 (en) * | 2006-03-24 | 2008-12-10 | Wyeth a Corporation of the State of Delaware | Methods for modulating bladder function |
AR060088A1 (es) * | 2006-03-24 | 2008-05-21 | Wyeth Corp | Metodos para tratar trastornos cognitivos y otros afines |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
-
2007
- 2007-03-23 WO PCT/US2007/007246 patent/WO2007112000A2/en active Application Filing
- 2007-03-23 PE PE2007000327A patent/PE20081192A1/es not_active Application Discontinuation
- 2007-03-23 AR ARP070101211A patent/AR060089A1/es unknown
- 2007-03-23 CA CA002644656A patent/CA2644656A1/en not_active Abandoned
- 2007-03-23 CN CNA2007800105001A patent/CN101410118A/zh active Pending
- 2007-03-23 BR BRPI0709163-0A patent/BRPI0709163A2/pt not_active Application Discontinuation
- 2007-03-23 PA PA20078720901A patent/PA8720901A1/es unknown
- 2007-03-23 AU AU2007230997A patent/AU2007230997A1/en not_active Abandoned
- 2007-03-23 JP JP2009502886A patent/JP2009531434A/ja not_active Withdrawn
- 2007-03-23 MX MX2008012092A patent/MX2008012092A/es not_active Application Discontinuation
- 2007-03-23 US US11/726,850 patent/US20070225277A1/en not_active Abandoned
- 2007-03-23 KR KR1020087023340A patent/KR20080110759A/ko not_active Application Discontinuation
- 2007-03-23 TW TW096110146A patent/TW200806299A/zh unknown
- 2007-03-23 EP EP07753842A patent/EP1998781A2/en not_active Withdrawn
-
2008
- 2008-08-28 IL IL193748A patent/IL193748A0/en unknown
- 2008-09-23 EC EC2008008762A patent/ECSP088762A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN101410118A (zh) | 2009-04-15 |
ECSP088762A (es) | 2008-10-31 |
MX2008012092A (es) | 2008-10-03 |
CA2644656A1 (en) | 2007-10-04 |
KR20080110759A (ko) | 2008-12-19 |
JP2009531434A (ja) | 2009-09-03 |
BRPI0709163A2 (pt) | 2011-06-28 |
US20070225277A1 (en) | 2007-09-27 |
WO2007112000A2 (en) | 2007-10-04 |
EP1998781A2 (en) | 2008-12-10 |
WO2007112000A3 (en) | 2008-01-17 |
AU2007230997A1 (en) | 2007-10-04 |
IL193748A0 (en) | 2009-08-03 |
TW200806299A (en) | 2008-02-01 |
PA8720901A1 (es) | 2008-11-19 |
PE20081192A1 (es) | 2008-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060089A1 (es) | Tratamiento del dolor | |
BRPI0607536A2 (pt) | tratamento de dor | |
MY196455A (en) | Nitrile-Containing Compounds Useful as Antiviral Agents for The Treatment of a Coronavirus Infection | |
ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
EA201071038A1 (ru) | Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
MX340965B (es) | Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular. | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
EA200971026A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
BRPI0407375A (pt) | Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos | |
AR044007A1 (es) | Metodos para el tratamiento de la enfermedad de parkinson | |
EA200971041A1 (ru) | Новые пептидные ингибиторы репликации вируса гепатита с | |
BR112014015482A8 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
NI200800169A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor | |
RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
BRPI0506493A (pt) | combinações terapêuticas | |
EA201071043A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1 | |
AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
ECSP099308A (es) | Métodos de tratamiento de la depresión | |
EA201071352A1 (ru) | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств | |
EA200970127A1 (ru) | Модулятор рецепторов глюкокортикостероидов и способы его применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |